ACLX
Price
$60.72
Change
-$4.88 (-7.44%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
3.34B
36 days until earnings call
XERS
Price
$5.08
Change
-$0.41 (-7.47%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
782.02M
35 days until earnings call
Ad is loading...

ACLX vs XERS

Header iconACLX vs XERS Comparison
Open Charts ACLX vs XERSBanner chart's image
Arcellx
Price$60.72
Change-$4.88 (-7.44%)
Volume$37.02K
Capitalization3.34B
Xeris Biopharma Holdings
Price$5.08
Change-$0.41 (-7.47%)
Volume$58.08K
Capitalization782.02M
ACLX vs XERS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. XERS commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and XERS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ACLX: $65.60 vs. XERS: $5.49)
Brand notoriety: ACLX and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 139% vs. XERS: 195%
Market capitalization -- ACLX: $3.34B vs. XERS: $782.02M
ACLX [@Biotechnology] is valued at $3.34B. XERS’s [@Biotechnology] market capitalization is $782.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, XERS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while XERS’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 6 bearish.
  • XERS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XERS is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -9.49% price change this week, while XERS (@Biotechnology) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

XERS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.34B) has a higher market cap than XERS($782M). XERS YTD gains are higher at: 61.947 vs. ACLX (-14.461). XERS has higher annual earnings (EBITDA): -13.99M vs. ACLX (-99.06M). ACLX has more cash in the bank: 587M vs. XERS (71.6M). ACLX has less debt than XERS: ACLX (54.1M) vs XERS (271M). XERS has higher revenues than ACLX: XERS (203M) vs ACLX (108M).
ACLXXERSACLX / XERS
Capitalization3.34B782M426%
EBITDA-99.06M-13.99M708%
Gain YTD-14.46161.947-23%
P/E RatioN/AN/A-
Revenue108M203M53%
Total Cash587M71.6M820%
Total Debt54.1M271M20%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXXERS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OWNS17.150.06
+0.36%
CCM Affordable Housing MBS ETF
CHFNZD1.99N/A
N/A
Switzerland Franc - New Zealand Dollar
NTSI37.98-0.16
-0.43%
WisdomTree International Efficnt Cr ETF
DIVI32.59-0.25
-0.76%
Franklin Intl Core Div Tlt Idx ETF
RTISX10.69-0.10
-0.93%
Russell Inv Multifactor Intl Eq S

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with KRYS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-3.47%
KRYS - ACLX
50%
Loosely correlated
-1.97%
DNLI - ACLX
49%
Loosely correlated
-8.02%
RCKT - ACLX
49%
Loosely correlated
-12.12%
SYRE - ACLX
46%
Loosely correlated
-10.06%
RNA - ACLX
46%
Loosely correlated
-6.58%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
-1.61%
TRDA - XERS
43%
Loosely correlated
-5.44%
KRYS - XERS
41%
Loosely correlated
-1.97%
ABOS - XERS
40%
Loosely correlated
-7.56%
FHTX - XERS
39%
Loosely correlated
+3.69%
ACLX - XERS
38%
Loosely correlated
-3.47%
More